Abstract:Utilizing Treg‐specific BATF‐deficient mice, the authors unravel the crucial role of BATF in transcriptional regulation of genes that are specific to Treg differentiation, maturation, homeostasis, and tissue adaptability. Mechanistically, it is found that BATF plays a critical role in maintaining Treg stability and preserving FOXP3 expression by controlling the demethylation status and accessibility of the CNS2 region within the Foxp3 locus. Regulatory T (Treg) cells are inevitable to prevent deleterious immune responses to self and commensal microorganisms. Treg function requires continuous expression of the transcription factor (TF) FOXP3 and is divided into two major subsets: resting (rTregs) and activated (aTregs). Continuous T cell receptor (TCR) signaling plays a vital role in the differentiation of aTregs from their resting state, and in their immune homeostasis. The process by which Tregs differentiate, adapt tissue specificity, and maintain stable phenotypic expression at the transcriptional level is still inconclusivei. In this work, the role of BATF is investigated, which is induced in response to TCR stimulation in naïve T cells and during aTreg differentiation. Mice lacking BATF in Tregs developed multiorgan autoimmune pathology. As a transcriptional regulator, BATF is required for Treg differentiation, homeostasis, and stabilization of FOXP3 expression in different lymphoid and non‐lymphoid tissues. Epigenetically, BATF showed direct regulation of Treg‐specific genes involved in differentiation, maturation, and tissue accumulation. Most importantly, FOXP3 expression and Treg stability require continuous BATF expression in Tregs, as it regulates demethylation and accessibility of the CNS2 region of the Foxp3 locus. Considering its role in Treg stability, BATF should be considered an important therapeutic target in autoimmune disease.

Batf-mediated Epigenetic Control of Effector CD8+ T Cell Differentiation

The transcription factor BATF pioneers the differentiation program of cytolytic effector CD8+ T cells through the direct interaction with IRF4

A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet

The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells

BATF regulates progenitor to cytolytic effector CD8+ T cell transition during chronic viral infection

Ablation of BATF Alleviates Transplant Rejection via Abrogating the Effector Differentiation and Memory Responses of CD8+ T Cells

BATF is Required for Treg Homeostasis and Stability to Prevent Autoimmune Pathology

<i>BATF</i>-mediated regulation of exhausted CD8<SUP>+</SUP> T-cell responses and potential implications for chimeric antigen receptor-T therapy

Transcriptional Programming of Dendritic Cells for Enhanced MHC Class II Antigen Presentation

BATF controls IFN I production via DC-SCRIPT in plasmacytoid dendritic cells

BATF-mediated regulation of exhausted CD8+ T-cell responses and potential implications for chimeric antigen receptor-T therapy

BATF-JUN is critical for IRF4-mediated transcription in T cells

Chromatin accessibility of CD8 T cell differentiation and metabolic regulation

Molecular Control of Follicular Helper T cell Development and Differentiation

Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin

Plasma cell differentiation is controlled by multiple cell division-coupled epigenetic programs

BATF3 programs CD8+ T cell memory

Th9 cell development requires a BATF-regulated transcriptional network

Cytotoxic Programming of CD4+ T Cells Is Regulated by Opposing Actions of the Related Transcription Factors Eos and Aiolos

Suppression of FOXP3 expression by the AP-1 family transcription factor BATF3 requires partnering with IRF4

BATF and BATF3 deficiency alters CD8+ effector/exhausted T cells balance in skin transplantation